A Case of Diffuse Infiltrative Hepatocellular Carcinoma with Marked Response to Sorafenib Treatment Evidenced by (18)F-FDG PET/MRI.


Özkan E., Demir B., Kuru Öz D., Ürün Y., Küçük N. Ö.

Molecular imaging and radionuclide therapy, cilt.33, sa.3, ss.193-195, 2024 (ESCI, TRDizin) identifier